Does TELOTRISTAT ETHYL Cause Hospitalisation? 235 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 235 reports of Hospitalisation have been filed in association with TELOTRISTAT ETHYL (Xermelo). This represents 4.2% of all adverse event reports for TELOTRISTAT ETHYL.
235
Reports of Hospitalisation with TELOTRISTAT ETHYL
4.2%
of all TELOTRISTAT ETHYL reports
20
Deaths
235
Hospitalizations
How Dangerous Is Hospitalisation From TELOTRISTAT ETHYL?
Of the 235 reports, 20 (8.5%) resulted in death, 235 (100.0%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELOTRISTAT ETHYL. However, 235 reports have been filed with the FAERS database.
What Other Side Effects Does TELOTRISTAT ETHYL Cause?
Diarrhoea (798)
Nausea (610)
Constipation (592)
Abdominal pain (514)
Off label use (495)
Fatigue (395)
Flatulence (390)
Flushing (344)
Headache (320)
Drug ineffective (317)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which TELOTRISTAT ETHYL Alternatives Have Lower Hospitalisation Risk?
TELOTRISTAT ETHYL vs TEMAZEPAM
TELOTRISTAT ETHYL vs TEMODAR
TELOTRISTAT ETHYL vs TEMOZOLOMIDE
TELOTRISTAT ETHYL vs TEMSIROLIMUS
TELOTRISTAT ETHYL vs TENAMFETAMINE